{"transactions":[{"id":733341,"issuer":{"id":7948,"kind":"organization","name":"Aprea Therapeutics, Inc."},"owners":[{"id":37129,"kind":"person","name":"BIZZARI JEAN-PIERRE","position":1,"cik":"0001630914","reported_name":"BIZZARI JEAN-PIERRE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2026-06-17T23:04:37.000Z","date":"2026-06-16","kind":"grant","planned":false,"acquired":true,"shares":12555,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in full on June 16, 2027, subject to the reporting person's continued service on the Issuer's board of directors through and including the applicable vesting date and subject to acceleration under certain conditions."}],"balance_after":12555,"derivative":{"exercise_price":0.7293,"expiration_date":"2036-06-16","underlying":"Common Stock","underlying_shares":12555},"source":{"system":"sec-edgar","filing":"0001104659-26-075281","document":"tm2618211-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1630914/000110465926075281/tm2618211-4_4seq1.xml","form_type":"4"}},{"id":733340,"issuer":{"id":7948,"kind":"organization","name":"Aprea Therapeutics, Inc."},"owners":[{"id":37129,"kind":"person","name":"BIZZARI JEAN-PIERRE","position":1,"cik":"0001630914","reported_name":"BIZZARI JEAN-PIERRE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-17T23:04:37.000Z","date":"2026-06-16","kind":"grant","planned":false,"acquired":true,"shares":3135,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units which were granted on June 16, 2026, and which will vest and be settled in common stock on June 16, 2027, subject to the reporting person's continued service on the Issuer's board of directors through and including the applicable vesting date and subject to acceleration under certain conditions."}],"balance_after":4180,"source":{"system":"sec-edgar","filing":"0001104659-26-075281","document":"tm2618211-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1630914/000110465926075281/tm2618211-4_4seq1.xml","form_type":"4"}},{"id":750830,"issuer":{"id":6502,"kind":"organization","name":"ADC Therapeutics SA"},"owners":[{"id":37129,"kind":"person","name":"BIZZARI JEAN-PIERRE","position":1,"cik":"0001630914","reported_name":"BIZZARI JEAN-PIERRE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2026-06-03T21:02:24.000Z","date":"2026-06-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":12600,"price":3.08,"value":38808.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents the number of Common Shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted share units previously granted."}],"balance_after":139302,"source":{"system":"sec-edgar","filing":"0001628280-26-040488","document":"wk-form4_1780520540.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1630914/000162828026040488/wk-form4_1780520540.xml","form_type":"4"}},{"id":750829,"issuer":{"id":6502,"kind":"organization","name":"ADC Therapeutics SA"},"owners":[{"id":37129,"kind":"person","name":"BIZZARI JEAN-PIERRE","position":1,"cik":"0001630914","reported_name":"BIZZARI JEAN-PIERRE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2026-06-03T21:02:24.000Z","date":"2026-06-01","kind":"grant","planned":false,"acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the annual grant of restricted stock units (\"RSUs\") made under the Issuer's 2019 Equity Incentive Plan for service as a Director. The RSUs vest on the earlier of (i) one year from the grant date or (ii) the date of the 2027 Annual Meeting of Shareholders, subject to the Reporting Person's continued service to the Issuer.  Each RSU represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":151902,"source":{"system":"sec-edgar","filing":"0001628280-26-040488","document":"wk-form4_1780520540.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1630914/000162828026040488/wk-form4_1780520540.xml","form_type":"4"}},{"id":1107456,"issuer":{"id":6502,"kind":"organization","name":"ADC Therapeutics SA"},"owners":[{"id":37129,"kind":"person","name":"BIZZARI JEAN-PIERRE","position":1,"cik":"0001630914","reported_name":"BIZZARI JEAN-PIERRE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2025-06-17T21:00:55.000Z","date":"2025-06-13","kind":"tax_withholding","planned":false,"acquired":false,"shares":12600,"price":3.58,"value":45108.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of Common Shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted share units previously granted."}],"balance_after":106902,"source":{"system":"sec-edgar","filing":"0001628280-25-031891","document":"wk-form4_1750194047.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1630914/000162828025031891/wk-form4_1750194047.xml","form_type":"4"}},{"id":1117358,"issuer":{"id":7948,"kind":"organization","name":"Aprea Therapeutics, Inc."},"owners":[{"id":37129,"kind":"person","name":"BIZZARI JEAN-PIERRE","position":1,"cik":"0001630914","reported_name":"BIZZARI JEAN-PIERRE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2025-06-09T20:01:14.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":4185,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in full on June 5, 2026, subject to the reporting person's continued service on the Issuer's board of directors through and including the applicable vesting date and subject to acceleration under certain conditions."}],"balance_after":4185,"derivative":{"exercise_price":1.81,"expiration_date":"2035-06-05","underlying":"Common Stock","underlying_shares":4185},"source":{"system":"sec-edgar","filing":"0001104659-25-057806","document":"tm2517366-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1630914/000110465925057806/tm2517366-1_4seq1.xml","form_type":"4"}},{"id":1117357,"issuer":{"id":7948,"kind":"organization","name":"Aprea Therapeutics, Inc."},"owners":[{"id":37129,"kind":"person","name":"BIZZARI JEAN-PIERRE","position":1,"cik":"0001630914","reported_name":"BIZZARI JEAN-PIERRE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-09T20:01:14.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":1045,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units which were granted on June 5, 2025, and which will vest and be settled in common stock on June 5, 2026, subject to the reporting person's continued service on the Issuer's board of directors through and including the applicable vesting date and subject to acceleration under certain conditions."}],"balance_after":1045,"source":{"system":"sec-edgar","filing":"0001104659-25-057806","document":"tm2517366-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1630914/000110465925057806/tm2517366-1_4seq1.xml","form_type":"4"}},{"id":1120881,"issuer":{"id":6502,"kind":"organization","name":"ADC Therapeutics SA"},"owners":[{"id":37129,"kind":"person","name":"BIZZARI JEAN-PIERRE","position":1,"cik":"0001630914","reported_name":"BIZZARI JEAN-PIERRE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2025-06-05T21:09:17.000Z","date":"2025-06-03","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the annual grant of restricted stock units (\"RSUs\") made under the Issuer's 2019 Equity Incentive Plan for service as a Director. The RSUs vest one year from the grant date, subject to the Reporting Person's\ncontinued service to the Issuer. Each RSU represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":119502,"source":{"system":"sec-edgar","filing":"0001628280-25-029735","document":"wk-form4_1749157731.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1630914/000162828025029735/wk-form4_1749157731.xml","form_type":"4"}},{"id":1474575,"issuer":{"id":6502,"kind":"organization","name":"ADC Therapeutics SA"},"owners":[{"id":37129,"kind":"person","name":"BIZZARI JEAN-PIERRE","position":1,"cik":"0001630914","reported_name":"BIZZARI JEAN-PIERRE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2024-06-19T01:43:50.000Z","date":"2024-06-17","kind":"sale","planned":false,"acquired":false,"shares":6995,"price":2.89,"value":20215.55,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents Common Shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of restricted share units."}],"balance_after":79502,"source":{"system":"sec-edgar","filing":"0001628280-24-028992","document":"wk-form4_1718761422.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1630914/000162828024028992/wk-form4_1718761422.xml","form_type":"4"}},{"id":1478462,"issuer":{"id":6502,"kind":"organization","name":"ADC Therapeutics SA"},"owners":[{"id":37129,"kind":"person","name":"BIZZARI JEAN-PIERRE","position":1,"cik":"0001630914","reported_name":"BIZZARI JEAN-PIERRE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2024-06-14T21:44:32.000Z","date":"2024-06-13","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the annual grant of restricted stock units (\"RSUs\") made under the Issuer's 2019 Equity Incentive Plan for service as a Director. The RSUs vest one year from the grant date, subject to the Reporting Person's continued service to the Issuer. Each RSU represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":86497,"source":{"system":"sec-edgar","filing":"0001628280-24-028355","document":"wk-form4_1718401463.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1630914/000162828024028355/wk-form4_1718401463.xml","form_type":"4"}},{"id":1797397,"issuer":{"id":7948,"kind":"organization","name":"Aprea Therapeutics, Inc."},"owners":[{"id":37129,"kind":"person","name":"BIZZARI JEAN-PIERRE","position":1,"cik":"0001630914","reported_name":"BIZZARI JEAN-PIERRE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2023-08-25T01:47:00.000Z","date":"2023-08-23","kind":"grant","planned":false,"acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options shall vest in full on the two year anniversary of the grant date, subject to the reporting person's continued service on the Issuer's board of Directors through and including the applicable vesting date."}],"balance_after":12500,"derivative":{"exercise_price":3.65,"expiration_date":"2033-08-23","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001104659-23-095014","document":"tm2324788-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1630914/000110465923095014/tm2324788-3_4seq1.xml","form_type":"4"}},{"id":1899758,"issuer":{"id":793,"kind":"organization","name":"HALOZYME THERAPEUTICS, INC.","symbol":"HALO"},"owners":[{"id":37129,"kind":"person","name":"BIZZARI JEAN-PIERRE","position":1,"cik":"0001630914","reported_name":"BIZZARI JEAN-PIERRE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2023-05-09T22:09:24.000Z","date":"2023-05-05","kind":"grant","planned":false,"acquired":true,"shares":11371,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Represents annual stock option grant under the Issuer's director compensation program.  This grant will vest in full on the earlier of (i) May 5, 2024 and (ii) the date of the Issuer's next annual meeting of stockholders."}],"balance_after":11371,"derivative":{"exercise_price":31,"exercise_date":"2024-05-05","expiration_date":"2033-05-05","underlying":"Common Stock","underlying_shares":11371},"source":{"system":"sec-edgar","filing":"0001415889-23-007687","document":"form4-05092023_100516.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1159036/000141588923007687/form4-05092023_100516.xml","form_type":"4"}},{"id":1899757,"issuer":{"id":793,"kind":"organization","name":"HALOZYME THERAPEUTICS, INC.","symbol":"HALO"},"owners":[{"id":37129,"kind":"person","name":"BIZZARI JEAN-PIERRE","position":1,"cik":"0001630914","reported_name":"BIZZARI JEAN-PIERRE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-09T22:09:24.000Z","date":"2023-05-05","kind":"grant","planned":false,"acquired":true,"shares":8065,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents annual restricted stock unit (\"RSU\") grant under the Issuer's director compensation program.   Each RSU represents the right to receive one share of common stock of the Issuer.  This grant will vest in full on the earlier of (i) May 5, 2024 and (ii) the date of the Issuer's next annual meeting of stockholders."}],"balance_after":66815,"source":{"system":"sec-edgar","filing":"0001415889-23-007687","document":"form4-05092023_100516.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1159036/000141588923007687/form4-05092023_100516.xml","form_type":"4"}},{"id":2279547,"issuer":{"id":793,"kind":"organization","name":"HALOZYME THERAPEUTICS, INC.","symbol":"HALO"},"owners":[{"id":37129,"kind":"person","name":"BIZZARI JEAN-PIERRE","position":1,"cik":"0001630914","reported_name":"BIZZARI JEAN-PIERRE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-05-07T00:04:20.000Z","date":"2022-05-05","kind":"grant","acquired":true,"shares":6206,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents annual restricted stock unit grant under the Issuer's director compensation program.  This grant will vest in full on the earlier of (i) May 5, 2023 and (ii) the date of the Issuer's next annual meeting of stockholders."}],"balance_after":58750,"source":{"system":"sec-edgar","filing":"0001179110-22-002906","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1159036/000117911022002906/edgar.xml","form_type":"4"}},{"id":2591129,"issuer":{"id":793,"kind":"organization","name":"HALOZYME THERAPEUTICS, INC.","symbol":"HALO"},"owners":[{"id":37129,"kind":"person","name":"BIZZARI JEAN-PIERRE","position":1,"cik":"0001630914","reported_name":"BIZZARI JEAN-PIERRE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-08-25T21:54:39.000Z","date":"2021-08-25","kind":"sale","acquired":false,"shares":35000,"price":41.013,"value":1435455.0,"ownership":{"direct":true},"balance_after":52544,"source":{"system":"sec-edgar","filing":"0001179110-21-008418","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1159036/000117911021008418/edgar.xml","form_type":"4"}},{"id":2725293,"issuer":{"id":793,"kind":"organization","name":"HALOZYME THERAPEUTICS, INC.","symbol":"HALO"},"owners":[{"id":37129,"kind":"person","name":"BIZZARI JEAN-PIERRE","position":1,"cik":"0001630914","reported_name":"BIZZARI JEAN-PIERRE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2021-05-07T00:00:56.000Z","date":"2021-05-05","kind":"grant","acquired":true,"shares":5230,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents annual restricted stock unit grant under the Issuer's director compensation program.  This grant will vest in full on the earlier of (i) May 5, 2022 and (ii) the date of the Issuer's next annual meeting of stockholders."}],"balance_after":87544,"source":{"system":"sec-edgar","filing":"0001179110-21-004969","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1159036/000117911021004969/edgar.xml","form_type":"4"}},{"id":3165586,"issuer":{"id":793,"kind":"organization","name":"HALOZYME THERAPEUTICS, INC.","symbol":"HALO"},"owners":[{"id":37129,"kind":"person","name":"BIZZARI JEAN-PIERRE","position":1,"cik":"0001630914","reported_name":"BIZZARI JEAN-PIERRE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-01T23:09:39.000Z","date":"2020-04-30","kind":"grant","acquired":true,"shares":8829,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents annual restricted stock grant under the Issuer's director compensation program.  This grant will vest in full on the earlier of (i) April 30, 2021 and (ii) the date of the Issuer's next annual meeting of stockholders."}],"balance_after":82314,"source":{"system":"sec-edgar","filing":"0001179110-20-005375","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1159036/000117911020005375/edgar.xml","form_type":"4"}},{"id":3299836,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":37129,"kind":"person","name":"BIZZARI JEAN-PIERRE","position":1,"cik":"0001630914","reported_name":"BIZZARI JEAN-PIERRE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-01-28T21:19:48.000Z","date":"2020-01-25","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option will vest as to 100% of the underlying shares on January 25, 2021, subject to the Reporting Person's continued service as a director through the vesting date."}],"balance_after":20000,"derivative":{"exercise_price":3.23,"expiration_date":"2030-01-25","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001562180-20-000620","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583648/000156218020000620/primarydocument.xml","form_type":"4"}},{"id":3540214,"issuer":{"id":793,"kind":"organization","name":"HALOZYME THERAPEUTICS, INC.","symbol":"HALO"},"owners":[{"id":37129,"kind":"person","name":"BIZZARI JEAN-PIERRE","position":1,"cik":"0001630914","reported_name":"BIZZARI JEAN-PIERRE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-03T20:07:42.000Z","date":"2019-05-02","kind":"grant","acquired":true,"shares":12173,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents annual restricted stock grant under the Issuer's director compensation program.  This grant will vest in full on the earlier of (i) May 2, 2020 and (ii) the date of the Issuer's next annual meeting of stockholders."}],"balance_after":73485,"source":{"system":"sec-edgar","filing":"0001179110-19-005497","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1159036/000117911019005497/edgar.xml","form_type":"4"}},{"id":3683434,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":37129,"kind":"person","name":"BIZZARI JEAN-PIERRE","position":1,"cik":"0001630914","reported_name":"BIZZARI JEAN-PIERRE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-01-29T22:35:49.000Z","date":"2019-01-25","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option will vest as to 100% of the underlying shares on January 25, 2020, subject to the Reporting Person's continued service as a director through the vesting date."}],"balance_after":20000,"derivative":{"exercise_price":2.74,"expiration_date":"2029-01-25","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001562180-19-000571","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583648/000156218019000571/primarydocument.xml","form_type":"4"}},{"id":3949887,"issuer":{"id":793,"kind":"organization","name":"HALOZYME THERAPEUTICS, INC.","symbol":"HALO"},"owners":[{"id":37129,"kind":"person","name":"BIZZARI JEAN-PIERRE","position":1,"cik":"0001630914","reported_name":"BIZZARI JEAN-PIERRE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-05-02T23:39:15.000Z","date":"2018-05-02","kind":"grant","acquired":true,"shares":10363,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents annual restricted stock grant under the Issuer's director compensation program.  This grant will vest in full on the earlier of (i) May 2, 2019 and (ii) the date of the Issuer's next annual meeting of stockholders."}],"balance_after":61312,"source":{"system":"sec-edgar","filing":"0001179110-18-006086","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1159036/000117911018006086/edgar.xml","form_type":"4"}},{"id":4086172,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":37129,"kind":"person","name":"BIZZARI JEAN-PIERRE","position":1,"cik":"0001630914","reported_name":"BIZZARI JEAN-PIERRE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-01-29T21:40:07.000Z","date":"2018-01-25","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option will vest in four equal installments on each of March 31, June 30, September 30 and December 31, 2018."}],"balance_after":20000,"derivative":{"exercise_price":7.72,"expiration_date":"2028-01-25","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001562180-18-000482","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583648/000156218018000482/primarydocument.xml","form_type":"4"}},{"id":4331838,"issuer":{"id":793,"kind":"organization","name":"HALOZYME THERAPEUTICS, INC.","symbol":"HALO"},"owners":[{"id":37129,"kind":"person","name":"BIZZARI JEAN-PIERRE","position":1,"cik":"0001630914","reported_name":"BIZZARI JEAN-PIERRE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-05-05T20:52:32.000Z","date":"2017-05-04","kind":"grant","acquired":true,"shares":14135,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents annual restricted stock grant under the Issuer's director compensation program.  This grant will vest in full on the earlier of (i) May 4, 2018 and (ii) the date of the Issuer's next annual meeting of stockholders."}],"balance_after":50949,"source":{"system":"sec-edgar","filing":"0001179110-17-006686","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1159036/000117911017006686/edgar.xml","form_type":"4"}},{"id":4476984,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":37129,"kind":"person","name":"BIZZARI JEAN-PIERRE","position":1,"cik":"0001630914","reported_name":"BIZZARI JEAN-PIERRE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-01-31T00:05:48.000Z","date":"2017-01-25","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option will vest in four equal installments on each of March 31, June 30, September 30, and December 31, 2017."}],"balance_after":20000,"derivative":{"exercise_price":2.01,"expiration_date":"2027-01-25","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0000899243-17-002208","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583648/000089924317002208/doc4.xml","form_type":"4"}}]}